(S (NP (NP (NNP Parkinson) (POS 's)) (NN disease)) (VP (VBZ is) (NP (NP (DT a) (JJ neurodegenerative) (NN disease)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB affect) (NP (NP (DT a) (NN person) (POS 's)) (NX (NN movement) (, ,) (NN speech) (, ,) (NN dexterity) (, ,) (CC and) (NN cognition))))))))) (. .))
(S (NP (NNS Clinicians)) (ADVP (RB primarily)) (VP (VBP diagnose) (NP (NP (NNP Parkinson) (POS 's)) (NN disease)) (PP (IN by) (S (VP (VBG performing) (NP (NP (DT a) (JJ clinical) (NN assessment)) (PP (IN of) (NP (NNS symptoms)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NNS misdiagnoses)) (VP (VBP are) (ADJP (JJ common))) (. .))
(S (NP (NP (CD One) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ contributes) (PP (TO to) (NP (NNS misdiagnoses))))))) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NP (NNP Parkinson) (POS 's)) (NN disease)))) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ prominent)) (PP (IN at) (NP (NP (DT the) (NN time)) (SBAR (S (NP (DT the) (JJ clinical) (NN assessment)) (VP (VBZ is) (VP (VBN performed)))))))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (JJ machine-learning) (NN approach)) (PP (NNS towards) (S (VP (S (VP (VBG distinguishing) (PP (IN between) (NP (NP (NNS people)) (PP (IN with) (CC and) (IN without) (NP (NP (NNP Parkinson) (POS 's)) (NN disease))))))) (S (VP (VBG using) (NP (NP (JJ long-term) (NNS data)) (PP (IN from) (NP (JJ smartphone-based) (NN walking) (, ,) (NN voice) (, ,) (VBG tapping) (CC and) (NN memory) (NNS tests))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (JJ attentive) (JJ deep-learning) (NNS models)) (VP (VBP achieve) (NP (NP (JJ significant) (NNS improvements)) (PP (IN in) (NP (JJ predictive) (NN performance))) (PP (IN over) (NP (NP (JJ strong) (NNS baselines)) (PRN (-LRB- -LRB-) (S (NP (NP (NN area)) (PP (IN under) (NP (DT the) (NN receiver) (VBG operating) (JJ characteristic) (NN curve)))) (VP (NNP =) (NP (CD 0.85)))) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NN data)) (PP (IN from) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (CD 1853) (NNS participants))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NNS models)) (VP (VB identify) (NP (NP (JJ meaningful) (NNS features)) (PP (IN in) (NP (DT the) (NN input) (NNS data)))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP confirm) (SBAR (IN that) (S (NP (NP (NN smartphone) (NNS data)) (VP (VBN collected) (PP (IN over) (NP (NP (JJ extended) (NNS periods)) (PP (IN of) (NP (NN time))))))) (VP (MD could) (PP (IN in) (NP (DT the) (NN future))) (ADVP (RB potentially)) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ digital) (NN biomarker)) (PP (IN for) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NP (NNP Parkinson) (POS 's)) (NN disease))))))))))))) (. .))
